Cargando…
Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy
Prostate cancer is the second most common cancer in men worldwide. Despite an abundance of prostate-specific antigens, immunotherapies have yet to become a standard of care, potentially limited by T-cell dysfunction. Up to 10% of human circulating T-cells, and a significant fraction in the urogenita...
Autores principales: | Jarvis, Ellie-May, Collings, Shaun, Authier-Hall, Astrid, Dasyam, Nathaniel, Luey, Brendan, Nacey, John, Painter, Gavin F., Delahunt, Brett, Hermans, Ian F., Weinkove, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560687/ https://www.ncbi.nlm.nih.gov/pubmed/34737749 http://dx.doi.org/10.3389/fimmu.2021.748741 |
Ejemplares similares
-
Conservation of mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, and abundance of MAIT cells in spleen
por: Goldfinch, Nick, et al.
Publicado: (2010) -
Mucosal-associated invariant T (MAIT) cells mediate protective host responses in sepsis
por: Trivedi, Shubhanshi, et al.
Publicado: (2020) -
Harnessing the Power of Mucosal-Associated Invariant T (MAIT) Cells in Cancer Cell Therapy
por: Sugimoto, Chie, et al.
Publicado: (2022) -
Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients
por: Ling, Limian, et al.
Publicado: (2016) -
Mucosal-Associated Invariant T (MAIT) Cells Are Impaired in Th17 Associated Primary and Secondary Immunodeficiencies
por: Gao, Yifang, et al.
Publicado: (2016)